| __timestamp | Viridian Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 3243000 | 2395000 |
| Thursday, January 1, 2015 | 2472000 | 9057000 |
| Friday, January 1, 2016 | 2548000 | 393000 |
| Sunday, January 1, 2017 | 19623000 | 79309000 |
| Monday, January 1, 2018 | 30421000 | 134428000 |
| Tuesday, January 1, 2019 | 32793999 | 175431000 |
| Wednesday, January 1, 2020 | 28304000 | 124165000 |
| Friday, January 1, 2021 | 620000 | 121875000 |
| Saturday, January 1, 2022 | 755000 | 10114000 |
| Sunday, January 1, 2023 | 1322000 | 9206000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis focuses on the cost of revenue for two pioneering companies: Wave Life Sciences Ltd. and Viridian Therapeutics, Inc., from 2014 to 2023.
Wave Life Sciences Ltd. has shown a remarkable increase in its cost of revenue, peaking in 2019 with a staggering 175 million USD, reflecting its aggressive expansion and investment in research. Despite a dip in 2022, the company maintained a robust average cost of revenue of approximately 67 million USD over the decade.
Conversely, Viridian Therapeutics, Inc. experienced a more volatile trajectory, with its highest cost of revenue reaching 33 million USD in 2019. The company faced significant fluctuations, with a notable drop in 2021, indicating strategic shifts or operational challenges.
These insights provide a window into the financial strategies and market positioning of these biotech leaders.
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Iovance Biotherapeutics, Inc. vs Viridian Therapeutics, Inc.